Your browser doesn't support javascript.
loading
Melanoma and intellectual disability: do prognostic factors at diagnosis differ from general population?
Lesage, C; Habib-Hadef, S; Trétarre, B; Lesage, F-X; Bessaoud, F; Varey, E; Guillot, B; Satgé, D.
Affiliation
  • Lesage C; Department of Dermatology, University Hospital, Montpellier, France.
  • Habib-Hadef S; ONCODEFI, Montpellier, France.
  • Trétarre B; Registre des Tumeurs de l'Hérault, Montpellier, France.
  • Lesage FX; Department of Professional pathologies, University of Montpellier, University Hospital Montpellier, Montpellier, France.
  • Varey E; Réseau pour la Recherche et l'Investigation Clinique sur le Mélanome, Nantes University Hospital, Nantes, France.
  • Guillot B; Department of Dermatology, University Hospital, Montpellier, France.
  • Satgé D; ONCODEFI, Montpellier, France.
J Intellect Disabil Res ; 66(4): 392-398, 2022 04.
Article in En | MEDLINE | ID: mdl-35137477
ABSTRACT

BACKGROUND:

Few melanoma cases are reported in individuals with intellectual disability (ID), and prognostic factors at diagnosis are unknown in this population. This work was designed to investigate whether prognostic factors at diagnostic are different in patients with ID compared with a general population.

METHODS:

Melanoma cases retrieved from Hérault's Tumour Registry (HTR) from 1995 to 2015 were cross-referenced against a list of adult patients with ID, living in Hérault. Major prognostic factors were compared with those in non-ID melanoma patients included in HTR and in patients followed by Montpellier University Hospital and included in the Réseau pour la Recherche et l'Investigation Clinique sur le Mélanome (RIC-Mel) database.

RESULTS:

Ten melanoma cases in individuals with ID were identified and compared with 3804 non-ID melanoma cases in HTR and 1024 non-ID melanoma cases included in RIC-Mel. Mean Breslow thickness at diagnosis was 4.6 mm in melanoma cases among those with ID versus 1.89 mm in HTR (P = 0.109) and 2.36 mm in RIC-Mel (P = 0.156). Stage at diagnosis was superior to stage IIB in 42.9% of ID cases versus 11.4% of non-ID cases in HTR (P < 0.05) and 8.5% in RIC-Mel (P < 0.05).

CONCLUSIONS:

Melanomas in patients with ID had less favourable prognostic factors at diagnosis, including higher Breslow thickness and more advanced stage, than melanomas in non-ID patients. These adverse prognostic factors indicate a later diagnosis in this population, leading to a poorer prognosis. This work underlines the need to improve melanoma screening among individuals with ID.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Skin Neoplasms / Melanoma / Intellectual Disability Type of study: Diagnostic_studies / Prognostic_studies Limits: Adult / Humans Language: En Journal: J Intellect Disabil Res Journal subject: TRANSTORNOS MENTAIS Year: 2022 Type: Article Affiliation country: France

Full text: 1 Database: MEDLINE Main subject: Skin Neoplasms / Melanoma / Intellectual Disability Type of study: Diagnostic_studies / Prognostic_studies Limits: Adult / Humans Language: En Journal: J Intellect Disabil Res Journal subject: TRANSTORNOS MENTAIS Year: 2022 Type: Article Affiliation country: France